Caris Life Sciences, Inc. (CAI)
34.33
-1.81
(-5.01%)
USD |
NASDAQ |
Oct 30, 16:00
34.32
-0.01
(-0.03%)
After-Hours: 20:00
Caris Life Sciences Cash from Operations (Annual) : 75.44M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 75.44M |
| December 31, 2024 | -245.20M |
| Date | Value |
|---|---|
| December 31, 2023 | -276.10M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Natera, Inc. | 215.30M |
| Myriad Genetics, Inc. | 1.80M |
| BioRestorative Therapies, Inc. | -10.79M |
| CareDx, Inc. | 42.03M |
| Exagen, Inc. | -13.62M |